Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Aanchal Sugandh

Is Eli Lilly Stock Underperforming the S&P 500?

Headquartered in Indianapolis, Indiana, Eli Lilly and Company (LLY) researches, develops, and markets medicines across cardiometabolic disease, oncology, immunology, neuroscience, and beyond. 

With a market capitalization of nearly $952.3 billion, it occupies “mega-cap” territory, an exclusive club reserved for companies valued above $200 billion. The scale allows the company to bankroll innovation, fortify global partnerships, and strengthen licensing alliances that keep its pipeline both deep and defensible.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.